Clinically approved NRTIs are frequently used in combination therapies to improve efficacy and reduce the risk of drug resistance. Notable examples include:
They compete with endogenous deoxynucleotides (like dTTP or dCTP) for binding to the viral Reverse Transcriptase (RT) enzyme . nucleoside reverse transcriptase inhibitor
NRTIs function as "prodrugs," meaning they are inactive upon entry and require by host cell kinases to become active triphosphate metabolites. Once activated, their mechanism follows two critical steps: Clinically approved NRTIs are frequently used in combination
The Role and Mechanism of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Once activated, their mechanism follows two critical steps:
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) are a foundational class of antiretroviral drugs used primarily in the treatment of HIV-1 infection. Often referred to as "nukes," these agents structurally mimic naturally occurring nucleosides (the building blocks of DNA) to interfere with the viral replication cycle.